Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 4275851, 9 pages
https://doi.org/10.1155/2017/4275851
Review Article

Relationship between Immunological Abnormalities in Rat Models of Diabetes Mellitus and the Amplification Circuits for Diabetes

1Department of Environmental and Preventive Medicine, Hyogo College of Medicine, Nishinomiya, Japan
2Department of Immunology, Faculty of Medicine, Yamagata University, Yamagata, Japan

Correspondence should be addressed to Yuji Takeda; pj.ca.u-atagamay.di.dem@adekat-uy

Received 20 July 2016; Revised 13 December 2016; Accepted 26 January 2017; Published 19 February 2017

Academic Editor: Akira Mima

Copyright © 2017 Yuji Takeda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas,” Physiological Research, vol. 50, no. 6, pp. 537–546, 2001. View at Google Scholar · View at Scopus
  2. S. Lenzen, “The mechanisms of alloxan- and streptozotocin-induced diabetes,” Diabetologia, vol. 51, no. 2, pp. 216–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. D. Muller, D. Golshayan, D. Ehirchiou et al., “Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells,” Diabetes, vol. 60, no. 9, pp. 2331–2340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. N. Gaulton, J. L. Schwartz, and D. D. Eardley, “Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice,” Diabetologia, vol. 28, no. 10, pp. 769–775, 1985. View at Publisher · View at Google Scholar · View at Scopus
  5. M. D. Buck, D. O'Sullivan, and E. L. Pearce, “T cell metabolism drives immunity,” Journal of Experimental Medicine, vol. 212, no. 9, pp. 1345–1360, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Boulikas, B. Bastin, P. Boulikas, and G. Dupuis, “Increase in histone poly(ADP-ribosylation) in mitogen-activated lymphoid cells,” Experimental Cell Research, vol. 187, no. 1, pp. 77–84, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Lautier, J. Lagueux, J. Thibodeau, L. Ménard, and G. G. Poirier, “Molecular and biochemical features of poly (ADP-ribose) metabolism,” Molecular and Cellular Biochemistry, vol. 122, no. 2, pp. 171–193, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Rubinstein, A. M. Genaro, A. Motta, G. Cremaschi, and M. R. Wald, “Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose,” Clinical and Experimental Immunology, vol. 154, no. 2, pp. 235–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ferracini, J. O. Martins, M. R. M. Campos, D. B. C. Anger, and S. Jancar, “Impaired phagocytosis by alveolar macrophages from diabetic rats is related to the deficient coupling of LTs to the FcγR signaling cascade,” Molecular Immunology, vol. 47, no. 11-12, pp. 1974–1980, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. G. B. Stefano, S. Challenger, and R. M. Kream, “Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders,” European Journal of Nutrition, vol. 55, no. 8, pp. 2339–2345, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. L. J. Slieker, E. F. Roberts, W. N. Shaw, and W. T. Johnson, “Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats,” Diabetes, vol. 39, no. 5, pp. 619–625, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Imagawa, T. Hanafusa, Y. Uchigata et al., “Fulminant type 1 diabetes: a nationwide survey in Japan,” Diabetes Care, vol. 26, no. 8, pp. 2345–2352, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Kobayashi, “Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM—the clinical characteristics and pathogenesis of the syndrome,” Diabetes Research and Clinical Practice, vol. 24, Supplement, pp. S95–S99, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Zimmet, R. Turner, D. McCarty, M. Rowley, and I. Mackay, “Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes,” Diabetes Care, vol. 22, supplement 2, pp. B59–B64, 1999. View at Google Scholar
  16. J. Van Den Brandt, H. J. Fischer, L. Walter, T. Hünig, I. Klöting, and H. M. Reichardt, “Type 1 diabetes in biobreeding rats is critically linked to an imbalance between Th17 and regulatory T cells and an altered TCR repertoire,” Journal of Immunology, vol. 185, no. 4, pp. 2285–2294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A.-M. Martin, E. P. Blankenhorn, M. N. Maxson et al., “Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat,” Diabetes, vol. 48, no. 1, pp. 50–58, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. H. Wallis, K. Wang, L. Marandi et al., “Type 1 diabetes in the BB rat: a polygenic disease,” Diabetes, vol. 58, no. 4, pp. 1007–1017, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. N. N. Iwakoshi, I. Goldschneider, F. Tausche, J. P. Mordes, A. A. Rossini, and D. L. Greiner, “High frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes-prone BioBreeding rats,” The Journal of Immunology, vol. 160, no. 12, pp. 5838–5850, 1998. View at Google Scholar · View at Scopus
  20. G. Hernández-Hoyos, S. Joseph, N. G. A. Miller, and G. W. Butcher, “The lymphopenia mutation of the BB rat causes inappropriate apoptosis of mature thymocytes,” European Journal of Immunology, vol. 29, no. 6, pp. 1832–1841, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Klöting, S. Berg, P. Kovács, B. Voigt, L. Vogt, and S. Schmidt, “Diabetes and hypertension in rodent models,” Annals of the New York Academy of Sciences, vol. 827, pp. 64–84, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Ramanathan, M.-T. Bihoreau, A. D. Paterson, L. Marandi, D. Gauguier, and P. Poussier, “Thymectomy and radiation-induced type 1 diabetes in nonlymphopenic BB rats,” Diabetes, vol. 51, no. 10, pp. 2975–2981, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. I. I. Mendez, Y.-H. Chung, H.-S. Jun, and J.-W. Yoon, “Immunoregulatory role of nitric oxide in Kilham rat virus-induced autoimmune diabetes in DR-BB rats,” The Journal of Immunology, vol. 173, no. 2, pp. 1327–1335, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. K. L. Kover, Z. Geng, D. M. Hess, C. D. Benjamin, and W. V. Moore, “Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat,” Diabetes, vol. 49, no. 10, pp. 1666–1670, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Lundsgaard, T. L. Holm, L. Hornum, and H. Markholst, “In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3,” Diabetes, vol. 54, no. 4, pp. 1040–1047, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Poussier, T. Ning, T. Murphy, D. Dabrowski, and S. Ramanathan, “Impaired post-thymic development of regulatory CD4+25 + T cells contributes to diabetes pathogenesis in BB rats,” Journal of Immunology, vol. 174, no. 7, pp. 4081–4089, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Bray, “The Zucker fatty rat: a review,” Federation Proceedings, vol. 36, no. 2, pp. 148–153, 1977. View at Google Scholar · View at Scopus
  28. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori, “Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain,” Diabetes, vol. 41, no. 11, pp. 1422–1428, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. B. J. Plotkin, D. Paulson, A. Chelich et al., “Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocyte function,” Journal of Medical Microbiology, vol. 44, no. 4, pp. 277–283, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. B. J. Plotkin and D. Paulson, “Zucker rat (fa/fa), a model for the study of immune function in Type-II diabetes mellitus: effect of exercise and caloric restriction on the phagocytic activity of macrophages,” Laboratory Animal Science, vol. 46, no. 6, pp. 682–684, 1996. View at Google Scholar · View at Scopus
  31. S.-I. Tanaka, F. Isoda, T. Yamakawa, M. Ishihara, and H. Sekihara, “T lymphopenia in genetically obese rats,” Clinical Immunology and Immunopathology, vol. 86, no. 2, pp. 219–225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Ruth, C. G. Taylor, P. Zahradka, and C. J. Field, “Abnormal immune responses in fa/fa Zucker rats and effects of feeding conjugated linoleic acid,” Obesity, vol. 16, no. 8, pp. 1770–1779, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Hirashima, K. Kawano, S. Mori, and T. Natori, “A diabetogenic gene, ODB2, identified on chromosome 14 of the OLETF rat and its synergistic action with ODB1,” Biochemical and Biophysical Research Communications, vol. 224, no. 2, pp. 420–425, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Nagai, T. Murao, Y. Ito, N. Okamoto, and H. Okamura, “Involvement of interleukin 18 in lens opacification of otsuka long-evans tokushima fatty rats, a model of human type 2 diabetes,” Current Eye Research, vol. 36, no. 6, pp. 497–506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. B. Clark, C. J. Palmer, and W. N. Shaw, “The diabetic zucker fatty rat,” Proceedings of the Society for Experimental Biology and Medicine, vol. 173, no. 1, pp. 68–75, 1983. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Ikeda, A. Shino, T. Matsuo, H. Iwatsuka, and Z. Suzuoki, “A new genetically obese-hyperglycemic rat (Wistar fatty),” Diabetes, vol. 30, no. 12, pp. 1045–1050, 1981. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Kaji, A. Okuno, K. Ohno-Ichiki et al., “Plasma profiles of glucose, insulin and lipids in the male WBN/Kob-leprfa rat, a new model of type 2 diabetes with obesity,” Journal of Veterinary Medical Science, vol. 74, no. 9, pp. 1185–1189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Matsui, M. Suzuki, R. Tsukuda, K. Iida, M. Miyasaka, and H. Ikeda, “Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty,” Diabetes Research and Clinical Practice, vol. 32, no. 1-2, pp. 1–9, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Noguchi, T. Matsuda, Y. Tomari et al., “The regulation of gene expression by insulin is differentially impaired in the liver of the genetically obese-hyperglycemic Wistar fatty rat,” FEBS Letters, vol. 328, no. 1-2, pp. 145–148, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. C. B. Landersdorfer, D. C. DuBois, R. R. Almon, and W. J. Jusko, “Mechanism-based modeling of nutritional and leptin influences on growth in normal and type 2 diabetic rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 328, no. 2, pp. 644–651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Kitahara, T. Toyota, M. Kakizaki, and Y. Goto, “Activities of hepatic enzymes in spontaneous diabetes rats produced by selective breeding of normal wistar rats,” Tohoku Journal of Experimental Medicine, vol. 126, no. 1, pp. 7–11, 1978. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Goto, M. Kakizaki, and N. Masaki, “Production of spontaneous diabetic rats by repetition of selective breeding,” Tohoku Journal of Experimental Medicine, vol. 119, no. 1, pp. 85–90, 1976. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Suzuki, T. Aizawa, N. Asanuma et al., “An early insulin intervention accelerates pancreatic β-cell dysfunction in young goto-kakizaki rats, a model of naturally occurring noninsulin-dependent diabetes,” Endocrinology, vol. 138, no. 3, pp. 1106–1110, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Homo-Delarche, S. Calderari, J. C. Irminger et al., “Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat,” Diabetes, vol. 55, no. 6, pp. 1625–1633, 2006. View at Publisher · View at Google Scholar
  45. A. H. Rosengren, R. Jokubka, D. Tojjar et al., “Overexpression of Alpha2A-Adrenergic receptors contributes to type 2 diabetes,” Science, vol. 327, no. 5962, pp. 217–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. F. M. Gribble, “α2A-adrenergic receptors and type 2 diabetes,” New England Journal of Medicine, vol. 362, no. 4, pp. 361–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Murakawa, W. Zhang, C. R. Pierson, T. Brismar, C.-G. Östenson, and A. A. F. Sima, “Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy,” Diabetes/Metabolism Research and Reviews, vol. 18, no. 6, pp. 473–483, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Shinohara, T. Masuyama, T. Shoda et al., “A new spontaneously diabetic non-obese torii rat strain with severe ocular complications,” Experimental Diabesity Research, vol. 1, no. 2, pp. 89–100, 2000. View at Google Scholar · View at Scopus
  49. T. Sasase, “Pathophysiological characteristics of diabetic ocular complications in spontaneously diabetic torii rat,” Journal of Ophthalmology, vol. 2010, Article ID 615641, 7 pages, 2010. View at Publisher · View at Google Scholar
  50. Y. Matsumoto, K. Torimoto, H. Matsuyoshi et al., “Long-term effects of diabetes mellitus on voiding function in a new model of type 2 diabetes mellitus, the Spontaneously Diabetic Torii (SDT) rat,” Biomedical Research, vol. 30, no. 6, pp. 331–335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Sasase, H. Morinaga, T. Abe et al., “Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat,” Diabetes, Obesity and Metabolism, vol. 11, no. 11, pp. 1084–1087, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Masuyama, Y. Katsuda, and M. Shinohara, “A novel model of obesity-related diabetes: introgression of the Leprfa allele of the zucker fatty rat into nonobese spontaneously diabetic torii (SDT) rats,” Experimental Animals, vol. 54, no. 1, pp. 13–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Ishii, M. Maki, H. Yamamoto, T. Sasase, M. Kakutani, and T. Ohta, “Blood pressure characteristics of female spontaneously diabetic Torii-Leprfa rats,” Journal of Veterinary Medical Science, vol. 73, no. 4, pp. 501–505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. I. Wakabayashi, T. Nakano, and Y. Takahashi, “Enhancement of interleukin-1β-induced iNOS expression in cultured vascular smooth muscle cells of Goto-Kakizaki diabetes rats,” European Journal of Pharmacology, vol. 629, no. 1–3, pp. 1–6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Takeda, M. Marumo, and I. Wakabayashi, “Attenuated phagocytic activity of monocytes in type 2 diabetic Goto-Kakizaki rats,” Immunobiology, vol. 216, no. 10, pp. 1094–1102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Takeda and I. Wakabayashi, “Alteration in lymphocyte population and humoral immune response in type 2 diabetic Goto-Kakizaki rats,” Life Sciences, vol. 90, no. 13-14, pp. 545–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Takeda, T. Shimomura, and I. Wakabayashi, “Immunological disorders of diabetes mellitus in experimental rat models,” Nihon eiseigaku zasshi. Japanese journal of hygiene, vol. 69, no. 3, pp. 166–176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. T. A. Wynn, A. Chawla, and J. W. Pollard, “Macrophage biology in development, homeostasis and disease,” Nature, vol. 496, no. 7446, pp. 445–455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Ginhoux and S. Jung, “Monocytes and macrophages: developmental pathways and tissue homeostasis,” Nature Reviews Immunology, vol. 14, no. 6, pp. 392–404, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. E. G. Perdiguero and F. Geissmann, “The development and maintenance of resident macrophages,” Nature Immunology, vol. 17, no. 1, pp. 2–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Okabe and R. Medzhitov, “Tissue biology perspective on macrophages,” Nature Immunology, vol. 17, no. 1, pp. 9–17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. C. K. Glass and G. Natoli, “Molecular control of activation and priming in macrophages,” Nature Immunology, vol. 17, no. 1, pp. 26–33, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. C. C. Bain, A. Bravo-Blas, C. L. Scott et al., “Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice,” Nature Immunology, vol. 15, no. 10, pp. 929–937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. F. Rivas, “In this issue: inflammation,” Cell, vol. 140, no. 6, p. 755, 757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. M. F. Gregor and G. S. Hotamisligil, “Inflammatory mechanisms in obesity,” Annual Review of Immunology, vol. 29, pp. 415–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. M. R. Dasu, S. Devaraj, L. Zhao, D. H. Hwang, and I. Jialal, “High glucose induces toll-like receptor expression in human monocytes mechanism of activation,” Diabetes, vol. 57, no. 11, pp. 3090–3098, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. M. R. Dasu, S. Devaraj, and I. Jialal, “High glucose induces IL-1β expression in human monocytes: mechanistic insights,” American Journal of Physiology - Endocrinology and Metabolism, vol. 293, no. 1, pp. E337–E346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Ichioka, T. Suganami, N. Tsuda et al., “Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans,” Diabetes, vol. 60, no. 3, pp. 819–826, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Pang, Y. Li, Y. Lv et al., “Intermedin restores hyperhomocysteinemia-induced macrophage polarization and improves insulin resistance in mice,” Journal of Biological Chemistry, vol. 291, no. 23, pp. 12336–12345, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Takeda, T. Kato, H. Ito et al., “The pattern of GPI-80 expression is a useful marker for unusual myeloid maturation in peripheral blood,” Clinical & Experimental Immunology, vol. 186, no. 3, pp. 373–386, 2016. View at Publisher · View at Google Scholar
  71. Y. Takeda, M. Marumo, H. Nara, Z.-G. Feng, H. Asao, and I. Wakabayashi, “Selective induction of anti-inflammatory monocyte-platelet aggregates in a model of pulsatile blood flow at low shear rates,” Platelets, vol. 27, no. 6, pp. 583–592, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. J. W. Semple, J. E. Italiano Jr., and J. Freedman, “Platelets and the immune continuum,” Nature Reviews Immunology, vol. 11, no. 4, pp. 264–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. Takeda, H. Nara, A. Araki, and H. Asao, “Human peripheral neutrophils express functional IL-21 receptors,” Inflammation, vol. 37, no. 5, pp. 1521–1532, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. M. S. Hayden and S. Ghosh, “NF-κB in immunobiology,” Cell Research, vol. 21, no. 2, pp. 223–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. D. B. Ballak, R. Stienstra, C. J. Tack, C. A. Dinarello, and J. A. van Diepen, “IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance,” Cytokine, vol. 75, no. 2, pp. 280–290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. D. Pal, S. Dasgupta, R. Kundu et al., “Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance,” Nature Medicine, vol. 18, no. 8, pp. 1279–1285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. T. B. Koenen, R. Stienstra, L. J. Van Tits et al., “Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1β transcription in human adipose tissue,” Diabetes, vol. 60, no. 2, pp. 517–524, 2011. View at Publisher · View at Google Scholar · View at Scopus